SYSU researchers identify antidepressant as potential breakthrough in overcoming ovarian cancer chemoresistance
A collaborative team led by Professor Chaoyun Pan from the Zhongshan School of Medicine has identified a neuro-immune-metabolic axis that drives chemoresistance, suggesting fluoxetine as a novel chemosensitizer.Ovarian cancer remains one of the most formidable challenges in women's health, claiming approximately 200,000 lives annually. While initial responses to cytoreductive surgery and platin...